{"id":47195,"date":"2022-08-11T16:02:09","date_gmt":"2022-08-11T14:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/"},"modified":"2022-08-11T16:02:09","modified_gmt":"2022-08-11T14:02:09","slug":"global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/","title":{"rendered":"Global Celiac Disease Drugs Market 2022-2026 &#8211; A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5454755\/global-celiac-disease-drugs-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7bd85v&amp;utm_campaign=1737361+-+Global+Celiac+Disease+Drugs+Market+2022-2026+-+A+Robust+Pipeline+and+Rise+in+Pharmaceutical+Expenditure+will+Lead+to+Sizable+Demand&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Celiac Disease Drugs Market 2022-2026&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95%\n<\/p>\n<p>\nThis study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, a robust pipeline and rise in pharmaceutical expenditure will lead to sizable demand in the market.\n<\/p>\n<p>\nThe market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac disease, and government initiatives.\n<\/p>\n<p>\nThe report on the celiac disease drugs market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The celiac disease drugs market analysis includes type segment and geographic landscape.\n<\/p>\n<p>\nThe robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors.\n<\/p>\n<p>\nAlso, the celiac disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Executive Summary<\/strong>\n<\/p>\n<p>\n1.1 Market overview\n<\/p>\n<p>\n<strong>2 Market Landscape<\/strong>\n<\/p>\n<p>\n2.1 Market ecosystem\n<\/p>\n<p>\n<strong>3 Market Sizing<\/strong>\n<\/p>\n<p>\n3.1 Market definition\n<\/p>\n<p>\n3.2 Market segment analysis\n<\/p>\n<p>\n3.3 Market size 2021\n<\/p>\n<p>\n3.4 Market outlook: Forecast for 2021-2026\n<\/p>\n<p>\n<strong>4 Five Forces Analysis<\/strong>\n<\/p>\n<p>\n4.1 Five forces summary\n<\/p>\n<p>\n4.2 Bargaining power of buyers\n<\/p>\n<p>\n4.3 Bargaining power of suppliers\n<\/p>\n<p>\n4.4 Threat of new entrants\n<\/p>\n<p>\n4.5 Threat of substitutes\n<\/p>\n<p>\n4.6 Threat of rivalry\n<\/p>\n<p>\n4.7 Market condition\n<\/p>\n<p>\n<strong>5 Market Segmentation by Therapy<\/strong>\n<\/p>\n<p>\n5.1 Market segments\n<\/p>\n<p>\n5.2 Comparison by Therapy\n<\/p>\n<p>\n5.3 First line treatment &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n5.4 Second line treatment &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n5.5 Market opportunity by Therapy\n<\/p>\n<p>\n<strong>6 Customer Landscape<\/strong>\n<\/p>\n<p>\n6.1 Customer landscape overview\n<\/p>\n<p>\n<strong>7 Geographic Landscape<\/strong>\n<\/p>\n<p>\n7.1 Geographic segmentation\n<\/p>\n<p>\n7.2 Geographic comparison\n<\/p>\n<p>\n7.3 North America &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.4 Europe &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.5 Asia &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.6 Rest of World (ROW) &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.7 US &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.8 Canada &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.9 Germany &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.10 UK &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.11 France &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.12 Market opportunity By Geographical Landscape\n<\/p>\n<p>\n<strong>8 Drivers, Challenges, and Trends<\/strong>\n<\/p>\n<p>\n8.1 Market drivers\n<\/p>\n<p>\n8.2 Market challenges\n<\/p>\n<p>\n8.3 Impact of drivers and challenges\n<\/p>\n<p>\n8.4 Market trends\n<\/p>\n<p>\n<strong>9 Vendor Landscape<\/strong>\n<\/p>\n<p>\n9.1 Overview\n<\/p>\n<p>\n9.2 Vendor landscape\n<\/p>\n<p>\n9.3 Landscape disruption\n<\/p>\n<p>\n9.4 Industry risks\n<\/p>\n<p>\n<strong>10 Vendor Analysis<\/strong>\n<\/p>\n<p>\n10.1 Vendors covered\n<\/p>\n<p>\n10.2 Market positioning of vendors\n<\/p>\n<ul>\n<li>\n9 Meters Biopharma Inc.\n<\/li>\n<li>\nAdaptive Biotechnologies Corp.\n<\/li>\n<li>\nAlmirall SA\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nAMYRA Biotech AG\n<\/li>\n<li>\nAvaxia Biologics Inc.\n<\/li>\n<li>\nBioLineRx Ltd.\n<\/li>\n<li>\nBristol Myers Squibb Co.\n<\/li>\n<li>\nCalypso Biotech\n<\/li>\n<li>\nGlaxoSmithKline Plc\n<\/li>\n<li>\nGlenmark Pharmaceuticals Ltd\n<\/li>\n<li>\nImmunogenics LLC\n<\/li>\n<li>\nJohnson and Johnson\n<\/li>\n<li>\nPrecigen Inc.\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTakeda Pharmaceutical Co. Ltd.\n<\/li>\n<li>\nTeva Pharmaceutical Industries Ltd.\n<\/li>\n<li>\nVactech Oy\n<\/li>\n<li>\nZedira GmbH\n<\/li>\n<li>\nArtielle Immunotherapeutics Inc\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5454755\/global-celiac-disease-drugs-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7bd85v&amp;utm_campaign=1737361+-+Global+Celiac+Disease+Drugs+Market+2022-2026+-+A+Robust+Pipeline+and+Rise+in+Pharmaceutical+Expenditure+will+Lead+to+Sizable+Demand&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/8s5ne2<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x70;&#114;&#x65;&#x73;&#115;&#64;&#x72;&#101;s&#x65;&#x61;&#114;&#x63;&#x68;&#97;n&#x64;&#109;a&#x72;&#x6b;&#101;&#x74;&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#x65;&#115;&#x73;&#x40;r&#x65;&#x73;e&#97;&#x72;c&#104;&#x61;n&#100;&#x6d;a&#114;&#x6b;e&#116;&#x73;&#x2e;&#99;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Celiac Disease Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-47195","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Celiac Disease Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-11T14:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Celiac Disease Drugs Market 2022-2026 &#8211; A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-11T14:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/\"},\"wordCount\":550,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220811005494\\\/en\\\/1542018\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/\",\"name\":\"Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220811005494\\\/en\\\/1542018\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-11T14:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220811005494\\\/en\\\/1542018\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220811005494\\\/en\\\/1542018\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Celiac Disease Drugs Market 2022-2026 &#8211; A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Celiac Disease Drugs Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-11T14:02:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Celiac Disease Drugs Market 2022-2026 &#8211; A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand &#8211; ResearchAndMarkets.com","datePublished":"2022-08-11T14:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/"},"wordCount":550,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/","name":"Global Celiac Disease Drugs Market 2022-2026 - A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg","datePublished":"2022-08-11T14:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220811005494\/en\/1542018\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-celiac-disease-drugs-market-2022-2026-a-robust-pipeline-and-rise-in-pharmaceutical-expenditure-will-lead-to-sizable-demand-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Celiac Disease Drugs Market 2022-2026 &#8211; A Robust Pipeline and Rise in Pharmaceutical Expenditure will Lead to Sizable Demand &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47195"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47195\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}